Report Detail

Chemical & Material Global Sex Hormone APIs Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

  • RnM4645173
  • |
  • 09 November, 2025
  • |
  • Global
  • |
  • 126 Pages
  • |
  • GIR
  • |
  • Chemical & Material

According to our (Global Info Research) latest study, the global Sex Hormone APIs market size was valued at US$ 193 million in 2024 and is forecast to a readjusted size of USD 1424 million by 2031 with a CAGR of 33.4% during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Sex hormone active pharmaceutical ingredients (APIs) are active substances used in the production of drugs related to sex hormones. These APIs primarily include estrogens, androgens, and progestogens, which are widely used in hormone replacement therapy, contraceptives, reproductive health treatments, and disorders related to sexual development. These APIs can be derived from natural sources or produced synthetically.
This report is a detailed and comprehensive analysis for global Sex Hormone APIs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Sex Hormone APIs market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global Sex Hormone APIs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global Sex Hormone APIs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global Sex Hormone APIs market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Sex Hormone APIs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Sex Hormone APIs market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Gongtong Pharmaceuticals, Renfu Pharmaceutical Group, Zhejiang Shenzhou Pharmaceuticals, Jiangsu Jiaerke Pharmaceuticals Group, Zhejiang Xianju Pharmaceuticals, Hubei Danao Pharmaceuticals, Jiangsu Kaiyuan Pharmaceuticals, Pfizer, Shanghai Pharmaceuticals Group, Farmabios, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Sex Hormone APIs market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Progesterone
Testosterone
Megestrol
Other
Market segment by Application
Dydrogesterone Tablets
Levonorgestrel Tablets
Progesterone Vaginal Sustained-release Gel
Other
Major players covered
Gongtong Pharmaceuticals
Renfu Pharmaceutical Group
Zhejiang Shenzhou Pharmaceuticals
Jiangsu Jiaerke Pharmaceuticals Group
Zhejiang Xianju Pharmaceuticals
Hubei Danao Pharmaceuticals
Jiangsu Kaiyuan Pharmaceuticals
Pfizer
Shanghai Pharmaceuticals Group
Farmabios
Progesterone API Market
Bayer
Sun Pharmaceutical Industries
Teva Pharmaceuticals
Aspen Pharmacare
Cipla
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Sex Hormone APIs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Sex Hormone APIs, with price, sales quantity, revenue, and global market share of Sex Hormone APIs from 2020 to 2025.
Chapter 3, the Sex Hormone APIs competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Sex Hormone APIs breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Sex Hormone APIs market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Sex Hormone APIs.
Chapter 14 and 15, to describe Sex Hormone APIs sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Sex Hormone APIs Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Progesterone
    • 1.3.3 Testosterone
    • 1.3.4 Megestrol
    • 1.3.5 Other
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Sex Hormone APIs Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Dydrogesterone Tablets
    • 1.4.3 Levonorgestrel Tablets
    • 1.4.4 Progesterone Vaginal Sustained-release Gel
    • 1.4.5 Other
  • 1.5 Global Sex Hormone APIs Market Size & Forecast
    • 1.5.1 Global Sex Hormone APIs Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Sex Hormone APIs Sales Quantity (2020-2031)
    • 1.5.3 Global Sex Hormone APIs Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Gongtong Pharmaceuticals
    • 2.1.1 Gongtong Pharmaceuticals Details
    • 2.1.2 Gongtong Pharmaceuticals Major Business
    • 2.1.3 Gongtong Pharmaceuticals Sex Hormone APIs Product and Services
    • 2.1.4 Gongtong Pharmaceuticals Sex Hormone APIs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Gongtong Pharmaceuticals Recent Developments/Updates
  • 2.2 Renfu Pharmaceutical Group
    • 2.2.1 Renfu Pharmaceutical Group Details
    • 2.2.2 Renfu Pharmaceutical Group Major Business
    • 2.2.3 Renfu Pharmaceutical Group Sex Hormone APIs Product and Services
    • 2.2.4 Renfu Pharmaceutical Group Sex Hormone APIs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Renfu Pharmaceutical Group Recent Developments/Updates
  • 2.3 Zhejiang Shenzhou Pharmaceuticals
    • 2.3.1 Zhejiang Shenzhou Pharmaceuticals Details
    • 2.3.2 Zhejiang Shenzhou Pharmaceuticals Major Business
    • 2.3.3 Zhejiang Shenzhou Pharmaceuticals Sex Hormone APIs Product and Services
    • 2.3.4 Zhejiang Shenzhou Pharmaceuticals Sex Hormone APIs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Zhejiang Shenzhou Pharmaceuticals Recent Developments/Updates
  • 2.4 Jiangsu Jiaerke Pharmaceuticals Group
    • 2.4.1 Jiangsu Jiaerke Pharmaceuticals Group Details
    • 2.4.2 Jiangsu Jiaerke Pharmaceuticals Group Major Business
    • 2.4.3 Jiangsu Jiaerke Pharmaceuticals Group Sex Hormone APIs Product and Services
    • 2.4.4 Jiangsu Jiaerke Pharmaceuticals Group Sex Hormone APIs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Jiangsu Jiaerke Pharmaceuticals Group Recent Developments/Updates
  • 2.5 Zhejiang Xianju Pharmaceuticals
    • 2.5.1 Zhejiang Xianju Pharmaceuticals Details
    • 2.5.2 Zhejiang Xianju Pharmaceuticals Major Business
    • 2.5.3 Zhejiang Xianju Pharmaceuticals Sex Hormone APIs Product and Services
    • 2.5.4 Zhejiang Xianju Pharmaceuticals Sex Hormone APIs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Zhejiang Xianju Pharmaceuticals Recent Developments/Updates
  • 2.6 Hubei Danao Pharmaceuticals
    • 2.6.1 Hubei Danao Pharmaceuticals Details
    • 2.6.2 Hubei Danao Pharmaceuticals Major Business
    • 2.6.3 Hubei Danao Pharmaceuticals Sex Hormone APIs Product and Services
    • 2.6.4 Hubei Danao Pharmaceuticals Sex Hormone APIs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Hubei Danao Pharmaceuticals Recent Developments/Updates
  • 2.7 Jiangsu Kaiyuan Pharmaceuticals
    • 2.7.1 Jiangsu Kaiyuan Pharmaceuticals Details
    • 2.7.2 Jiangsu Kaiyuan Pharmaceuticals Major Business
    • 2.7.3 Jiangsu Kaiyuan Pharmaceuticals Sex Hormone APIs Product and Services
    • 2.7.4 Jiangsu Kaiyuan Pharmaceuticals Sex Hormone APIs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Jiangsu Kaiyuan Pharmaceuticals Recent Developments/Updates
  • 2.8 Pfizer
    • 2.8.1 Pfizer Details
    • 2.8.2 Pfizer Major Business
    • 2.8.3 Pfizer Sex Hormone APIs Product and Services
    • 2.8.4 Pfizer Sex Hormone APIs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Pfizer Recent Developments/Updates
  • 2.9 Shanghai Pharmaceuticals Group
    • 2.9.1 Shanghai Pharmaceuticals Group Details
    • 2.9.2 Shanghai Pharmaceuticals Group Major Business
    • 2.9.3 Shanghai Pharmaceuticals Group Sex Hormone APIs Product and Services
    • 2.9.4 Shanghai Pharmaceuticals Group Sex Hormone APIs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Shanghai Pharmaceuticals Group Recent Developments/Updates
  • 2.10 Farmabios
    • 2.10.1 Farmabios Details
    • 2.10.2 Farmabios Major Business
    • 2.10.3 Farmabios Sex Hormone APIs Product and Services
    • 2.10.4 Farmabios Sex Hormone APIs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Farmabios Recent Developments/Updates
  • 2.11 Progesterone API Market
    • 2.11.1 Progesterone API Market Details
    • 2.11.2 Progesterone API Market Major Business
    • 2.11.3 Progesterone API Market Sex Hormone APIs Product and Services
    • 2.11.4 Progesterone API Market Sex Hormone APIs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 Progesterone API Market Recent Developments/Updates
  • 2.12 Bayer
    • 2.12.1 Bayer Details
    • 2.12.2 Bayer Major Business
    • 2.12.3 Bayer Sex Hormone APIs Product and Services
    • 2.12.4 Bayer Sex Hormone APIs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 Bayer Recent Developments/Updates
  • 2.13 Sun Pharmaceutical Industries
    • 2.13.1 Sun Pharmaceutical Industries Details
    • 2.13.2 Sun Pharmaceutical Industries Major Business
    • 2.13.3 Sun Pharmaceutical Industries Sex Hormone APIs Product and Services
    • 2.13.4 Sun Pharmaceutical Industries Sex Hormone APIs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.13.5 Sun Pharmaceutical Industries Recent Developments/Updates
  • 2.14 Teva Pharmaceuticals
    • 2.14.1 Teva Pharmaceuticals Details
    • 2.14.2 Teva Pharmaceuticals Major Business
    • 2.14.3 Teva Pharmaceuticals Sex Hormone APIs Product and Services
    • 2.14.4 Teva Pharmaceuticals Sex Hormone APIs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.14.5 Teva Pharmaceuticals Recent Developments/Updates
  • 2.15 Aspen Pharmacare
    • 2.15.1 Aspen Pharmacare Details
    • 2.15.2 Aspen Pharmacare Major Business
    • 2.15.3 Aspen Pharmacare Sex Hormone APIs Product and Services
    • 2.15.4 Aspen Pharmacare Sex Hormone APIs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.15.5 Aspen Pharmacare Recent Developments/Updates
  • 2.16 Cipla
    • 2.16.1 Cipla Details
    • 2.16.2 Cipla Major Business
    • 2.16.3 Cipla Sex Hormone APIs Product and Services
    • 2.16.4 Cipla Sex Hormone APIs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.16.5 Cipla Recent Developments/Updates

3 Competitive Environment: Sex Hormone APIs by Manufacturer

  • 3.1 Global Sex Hormone APIs Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Sex Hormone APIs Revenue by Manufacturer (2020-2025)
  • 3.3 Global Sex Hormone APIs Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Sex Hormone APIs by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Sex Hormone APIs Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Sex Hormone APIs Manufacturer Market Share in 2024
  • 3.5 Sex Hormone APIs Market: Overall Company Footprint Analysis
    • 3.5.1 Sex Hormone APIs Market: Region Footprint
    • 3.5.2 Sex Hormone APIs Market: Company Product Type Footprint
    • 3.5.3 Sex Hormone APIs Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Sex Hormone APIs Market Size by Region
    • 4.1.1 Global Sex Hormone APIs Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Sex Hormone APIs Consumption Value by Region (2020-2031)
    • 4.1.3 Global Sex Hormone APIs Average Price by Region (2020-2031)
  • 4.2 North America Sex Hormone APIs Consumption Value (2020-2031)
  • 4.3 Europe Sex Hormone APIs Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Sex Hormone APIs Consumption Value (2020-2031)
  • 4.5 South America Sex Hormone APIs Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Sex Hormone APIs Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Sex Hormone APIs Sales Quantity by Type (2020-2031)
  • 5.2 Global Sex Hormone APIs Consumption Value by Type (2020-2031)
  • 5.3 Global Sex Hormone APIs Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Sex Hormone APIs Sales Quantity by Application (2020-2031)
  • 6.2 Global Sex Hormone APIs Consumption Value by Application (2020-2031)
  • 6.3 Global Sex Hormone APIs Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Sex Hormone APIs Sales Quantity by Type (2020-2031)
  • 7.2 North America Sex Hormone APIs Sales Quantity by Application (2020-2031)
  • 7.3 North America Sex Hormone APIs Market Size by Country
    • 7.3.1 North America Sex Hormone APIs Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Sex Hormone APIs Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Sex Hormone APIs Sales Quantity by Type (2020-2031)
  • 8.2 Europe Sex Hormone APIs Sales Quantity by Application (2020-2031)
  • 8.3 Europe Sex Hormone APIs Market Size by Country
    • 8.3.1 Europe Sex Hormone APIs Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Sex Hormone APIs Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Sex Hormone APIs Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Sex Hormone APIs Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Sex Hormone APIs Market Size by Region
    • 9.3.1 Asia-Pacific Sex Hormone APIs Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Sex Hormone APIs Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Sex Hormone APIs Sales Quantity by Type (2020-2031)
  • 10.2 South America Sex Hormone APIs Sales Quantity by Application (2020-2031)
  • 10.3 South America Sex Hormone APIs Market Size by Country
    • 10.3.1 South America Sex Hormone APIs Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Sex Hormone APIs Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Sex Hormone APIs Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Sex Hormone APIs Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Sex Hormone APIs Market Size by Country
    • 11.3.1 Middle East & Africa Sex Hormone APIs Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Sex Hormone APIs Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Sex Hormone APIs Market Drivers
  • 12.2 Sex Hormone APIs Market Restraints
  • 12.3 Sex Hormone APIs Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Sex Hormone APIs and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Sex Hormone APIs
  • 13.3 Sex Hormone APIs Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Sex Hormone APIs Typical Distributors
  • 14.3 Sex Hormone APIs Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Sex Hormone APIs. Industry analysis & Market Report on Sex Hormone APIs is a syndicated market report, published as Global Sex Hormone APIs Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Sex Hormone APIs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,690.04
    4,035.06
    5,380.08
    3,239.88
    4,859.82
    6,479.76
    531,361.20
    797,041.80
    1,062,722.40
    293,712.00
    440,568.00
    587,424.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report